Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats. (Q47948506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Murat Aydın

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Nejat Altintas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Mustafa Erboga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Cevat Aktas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Aysun Sengul

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Zehra Ates

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Birol Topcu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ahmet Gurel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

1 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

65-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253295%20AND%20SRC:MED&resulttype=core&format=json

Translational models of lung disease

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Oxidative stress in the pathogenesis of diffuse lung diseases: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Luteolin Ameliorates Experimental Lung Fibrosis Both in Vivo and in Vitro: Implications for Therapy of Lung Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Standardized quantification of pulmonary fibrosis in histological samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

The effect of methylene blue treatment on aspiration pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

21 January 2018

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Modeling pulmonary fibrosis with bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Tumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Novel approaches to pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Soluble TNF mediates the transition from pulmonary inflammation to fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Infliximab attenuates inflammatory osteolysis in a model of periodontitis in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-015-0224-Z

Microplate assay for the measurement of hydroxyproline in acid-hydrolyzed tissue samples

21 January 2018

1 reference

12 December 2020

A simple method for clinical assay of superoxide dismutase

1 reference

12 December 2020

Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method

1 reference

12 December 2020

Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase

1 reference

12 December 2020

Anti-tumour necrosis factor therapy for severe inflammatory arthritis: two years of experience in Northern Ireland.

1 reference

12 December 2020

Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)

1 reference

12 December 2020

Cytokines and pulmonary fibroses

1 reference

12 December 2020

Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta

1 reference

12 December 2020

Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro

1 reference

12 December 2020

Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis

1 reference

12 December 2020

Malondialdehyde determination as index of lipid peroxidation

1 reference

12 December 2020

Drug-induced pulmonary fibrosis

1 reference

12 December 2020

Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts

1 reference

12 December 2020

Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice

1 reference

12 December 2020

Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease

1 reference

12 December 2020

Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats

1 reference

12 December 2020

Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Severe interstitial pneumonitis associated with infliximab therapy

1 reference

12 December 2020

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung

1 reference

12 December 2020